Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA209275
Max Phase: Preclinical
Molecular Formula: C51H81N7O11
Molecular Weight: 968.25
Molecule Type: Small molecule
Associated Items:
ID: ALA209275
Max Phase: Preclinical
Molecular Formula: C51H81N7O11
Molecular Weight: 968.25
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O
Standard InChI: InChI=1S/C51H81N7O11/c1-6-7-8-9-10-11-12-13-14-15-19-25-42(62)56-44(34(4)59)50(67)57-43(33(2)3)48(65)58-45(35(5)60)49(66)54-40(31-37-26-28-38(61)29-27-37)47(64)53-39(24-20-21-30-52)46(63)55-41(51(68)69)32-36-22-17-16-18-23-36/h16-18,22-23,26-29,33-35,39-41,43-45,59-61H,6-15,19-21,24-25,30-32,52H2,1-5H3,(H,53,64)(H,54,66)(H,55,63)(H,56,62)(H,57,67)(H,58,65)(H,68,69)/t34-,35-,39+,40+,41+,43+,44+,45+/m1/s1
Standard InChI Key: FRXCNTKLYDTMQD-FUFDYEGGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 968.25 | Molecular Weight (Monoisotopic): 967.5994 | AlogP: 3.42 | #Rotatable Bonds: 35 |
Polar Surface Area: 298.61 | Molecular Species: ZWITTERION | HBA: 11 | HBD: 11 |
#RO5 Violations: 3 | HBA (Lipinski): 18 | HBD (Lipinski): 12 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.70 | CX Basic pKa: 17.64 | CX LogP: 2.39 | CX LogD: 2.39 |
Aromatic Rings: 2 | Heavy Atoms: 69 | QED Weighted: 0.04 | Np Likeness Score: 0.23 |
1. Basse N, Papapostolou D, Pagano M, Reboud-Ravaux M, Bernard E, Felten AS, Vanderesse R.. (2006) Development of lipopeptides for inhibiting 20S proteasomes., 16 (12): [PMID:16630721] [10.1016/j.bmcl.2006.03.033] |
Source(1):